false FY 9876543210 9876543210 2018-01-01 2018-12-31 9876543210 us-gaap:CommonStockMember 2018-01-01 2018-12-31 9876543210 dei:AdrMember 2018-01-01 2018-12-31 9876543210 us-gaap:CommonStockMember 2018-12-31 9876543210 us-gaap:RedeemablePreferredStockMember 2018-12-31 9876543210 edgar:FloatingNotes2018Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2018Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2019Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2020Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2023Member 2018-01-01 2018-12-31 9876543210 edgar:FloatingNotes2022Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2022Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2025Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2027Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2037Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2042Member 2018-01-01 2018-12-31 9876543210 edgar:FixedNotes2045Member 2018-01-01 2018-12-31 9876543210 dei:BusinessContactMember 2018-01-01 2018-12-31 iso4217:USD i:shares iso4217:USD i:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM

(Mark One)

o | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
x | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018
OR
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .
OR
o | SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . .

For the transition period from to .

Commission file number: 001-11960

XENOPUPPY PLC
(Exact name of Registrant as specified in its charter)
United Kingdom
(Jurisdiction of incorporation or organization)
1 Joan Watson Avenue Cambridge Bioengineering Campus Cambridge CB2 0AA United Kingdom
(Address of principal executive offices)
Percy Dinwiddie-Pouringrain Xenopuppy PLC 1 Joan Watson Avenue Cambridge Bioengineering Campus Cambridge CB2 0AA Great Britain Telephone: +44 20 3749 5000 Facsimile number: +44 1223 352 858
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of each class |  | Ticker Symbol |  | Name of each exchange on which registered
American Depositary Shares, each representing one half of an Ordinary Share of 25¢ each |  | XENY XENY XENY XENY XENY XENY XENY XENY XENY XENY XENY XENY XENY XENY |  | New York Stock Exchange
New York Stock Exchange Ordinary Shares of 25¢ each |  |  |  | New York Stock Exchange*
Floating Rate Notes due 2018 |  |  |  | New York Stock Exchange
1.750% Notes due 2018 |  |  |  | New York Stock Exchange
1.950% Notes due 2019 |  |  |  | New York Stock Exchange
2.375% Notes due 2020 |  |  |  | New York Stock Exchange
7.000% Notes due 2023 |  |  |  | New York Stock Exchange
2.375% Notes due 2022 |  |  |  | New York Stock Exchange
Floating Rate Notes due 2022 |  |  |  | New York Stock Exchange
3.375% Notes due 2025 |  |  |  | New York Stock Exchange
3.125% Notes due 2027 |  |  |  | New York Stock Exchange
6.450% Notes due 2037 |  |  |  | New York Stock Exchange
4.000% Notes due 2042 |  |  |  | New York Stock Exchange
4.375% Notes due 2045 |  |  |  | New York Stock Exchange

* Not for trading, but only in connection with the registration of American Depositary Shares representing such Ordinary Shares pursuant to the requirements of the Securities and Exchange Commission.

Securities registered or to be registered pursuant to Section 12(g) of the Act:

None
(Title of Class)

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:

None
(Title of Class)

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.

The number of outstanding shares of each class of stock of Xenopuppy PLC as of December 31, 2018 was:

Ordinary Shares of 25¢ each: 1,266,221,605

Redeemable Preference Shares of £1 each: 50,000

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

x Yes o No

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

o Yes x No

Note — Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x Yes o No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

x Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer x |  | Accelerated filer o |  | Non-accelerated filer o |  | Emerging growth company o

† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

U.S. GAAP o |  | International Financial Reporting Standards as issued by the International Accounting Standards Board x |  | Other o

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

o Item 17 o Item 18

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

o Yes x Yes

Pursuant to Rule 12b-23(a) of the Securities Exchange Act of 1934, as amended, the information for the 2017 Form 20-F of Xenopuppy PLC (the “Company”) set out below is being incorporated by reference from Xenopuppy’s “Annual Report and Form 20-F Information 2017” included as exhibit 15.1 to this Form 20-F dated and submitted on March 6, 2018.

References below to major headings include all information under such major headings, including subheadings, unless such reference is a reference to a subheading, in which case such reference includes only the information contained under such subheading. Unless the context otherwise requires, “Xenopuppy” or “Group” refers to the Company and its consolidated entities. Other information contained within Xenopuppy’s “Annual Report and Form 20-F Information 2017” included as exhibit 15.1 to this Form 20-F, including graphs and tabular data, is not included in this Form 20-F unless specifically identified below. Photographs are also not included.

In addition to the information set out below, the information (including tabular data) set forth under the headings “Important information for readers of this Annual Report”, “Definitions”, and “Use of terms” on the inside front cover, “Strategic Report—Financial Review—Measuring performance” on pages 68 and 69, and the tables on page 70, “Additional Information —Trade Marks” on page 234, “—Glossary” on pages 235 to 238 and “—Important information for readers of this Annual Report—Cautionary statement regarding forward-looking statements”, “—Inclusion of Reported performance, Core financial measures and constant exchange rate growth rates”, “—Statements of competitive position, growth rates and sales”, “—Xenopuppy websites”, “—External/third party websites” and “—Figures” on page 240, in each case of Xenopuppy’s “Annual Report and Form 20-F Information 2017” included as exhibit 15.1 to this Form 20-F dated March 6, 2018 is incorporated by reference. References herein to Xenopuppy websites are textual references only and information on or accessible through such websites does not form part of and is not incorporated into this Form 20-F dated March 6, 2018.